Veronica Juarez

Veronica Juarez has a diverse work experience in the biotech and pharmaceutical industry. Veronica is currently working as the Vice President, Program Lead at Akouos, where they are responsible for guiding the cross-functional anti-VEGF program team. Prior to that, they worked as the Executive Director, Portfolio and Program Management at Cognoa, leading the development of digital diagnostics and therapeutics for pediatric behavioral health.

Veronica has also held senior leadership positions at Audentes Therapeutics, Atara Biotherapeutics, Agios Pharmaceuticals, Genentech, Janssen Alzheimer Immunotherapy Research and Development, Elan, and Genentech (previous role). In these roles, they have been involved in strategic planning, program management, operational excellence, budget oversight, and cross-functional collaboration for various medical affairs and clinical trial projects.

Throughout their career, Veronica has demonstrated a strong ability to drive development strategies, manage teams, and ensure the successful implementation of projects. Veronica has also shown expertise in planning, execution, and budget management. Their experience spans across different therapeutic areas, including hearing loss, behavioral health, Alzheimer's disease, and oncology.

Veronica Juarez completed their undergraduate education at the University of California, Davis, from 1993 to 1998. Veronica obtained a Bachelor of Science degree with a major in Biochemistry during this period. In 2013 and 2014, Veronica attended Stanford University for an Advanced Program Management Professional Certification. The exact field of study for this program is not specified. Additionally, they received a Certificate in Clinical Trials Design and Management from the University of California, Santa Cruz. The time frame for this certificate program is not provided.